T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation
- PMID: 2012626
- DOI: 10.1002/art.1780340404
T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation
Abstract
The cellular immune response to Borrelia burgdorferi was studied in 24 patients with seropositive and seronegative Lyme borreliosis, 30 patients with arthritides of different origin (non-Lyme arthritides), and 20 normal blood donors. By far, the strongest T cell stimulation was induced by incubation with autologous serum; there was a significantly lower response or no response after incubation with allogeneic or heterologous sera. In patients with Lyme borreliosis, including seronegative patients, there was a strikingly elevated proliferation in response to whole B burgdorferi bacteria (mean 64,750 dpm) compared with that of normal donors (mean 19,700 dpm; P less than 0.0001) and especially that of non-Lyme arthritis patients (mean 11,600 dpm; P less than 0.0001). Levels of proliferation declined significantly in patients with Lyme borreliosis after successful antibiotic treatment. Parallel cultures using B burgdorferi and Treponema phagedenis as antigens showed that cells from patients with Lyme borreliosis responded significantly more to B burgdorferi than to T phagedenis, but this did not occur with cells from individuals with non-Lyme arthritides. There was no correlation between disease stages and proliferation values. These data indicate that lymphocyte proliferation assays may provide an important tool for the diagnosis of Lyme borreliosis, most notably in patients with arthritides and in those who are seronegative. Conversely, the lack of reactivity appears to be a strong indicator of the absence of active Lyme disease. It seems to be crucial, however, to use autologous sera in these assays.
Similar articles
-
Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.J Clin Invest. 1992 Sep;90(3):1077-84. doi: 10.1172/JCI115923. J Clin Invest. 1992. PMID: 1522216 Free PMC article.
-
Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.Arch Dermatol. 1995 Jun;131(6):673-7. Arch Dermatol. 1995. PMID: 7778918
-
Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.J Infect Dis. 1994 Feb;169(2):313-8. doi: 10.1093/infdis/169.2.313. J Infect Dis. 1994. PMID: 8106763
-
Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis.Behring Inst Mitt. 1991 Feb;(88):52-8. Behring Inst Mitt. 1991. PMID: 2049046 Review. No abstract available.
-
Immunologic aspects of Lyme borreliosis.Rev Infect Dis. 1989 Sep-Oct;11 Suppl 6:S1494-8. doi: 10.1093/clinids/11.supplement_6.s1494. Rev Infect Dis. 1989. PMID: 2682961 Review.
Cited by
-
Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.Infect Immun. 1997 Jul;65(7):2829-36. doi: 10.1128/iai.65.7.2829-2836.1997. Infect Immun. 1997. PMID: 9199456 Free PMC article.
-
Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse.Infect Immun. 1993 May;61(5):1814-22. doi: 10.1128/iai.61.5.1814-1822.1993. Infect Immun. 1993. PMID: 8478071 Free PMC article.
-
Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology.Clin Diagn Lab Immunol. 1994 Jul;1(4):373-8. doi: 10.1128/cdli.1.4.373-378.1994. Clin Diagn Lab Immunol. 1994. PMID: 8556471 Free PMC article.
-
Lyme arthritis.Ann Rheum Dis. 1994 Sep;53(9):553-6. doi: 10.1136/ard.53.9.553. Ann Rheum Dis. 1994. PMID: 7979590 Free PMC article. Review. No abstract available.
-
The lymphocyte transformation test for borrelia detects active lyme borreliosis and verifies effective antibiotic treatment.Open Neurol J. 2012;6:104-12. doi: 10.2174/1874205X01206010104. Epub 2012 Oct 5. Open Neurol J. 2012. PMID: 23091571 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical